AVASX
Price
$22.93
Change
+$0.21 (+0.92%)
Updated
Aug 4 closing price
Net Assets
3.24B
RMFEX
Price
$60.09
Change
+$0.76 (+1.28%)
Updated
Aug 4 closing price
Net Assets
107.77B
Interact to see
Advertisement

AVASX vs RMFEX

Header iconAVASX vs RMFEX Comparison
Open Charts AVASX vs RMFEXBanner chart's image
American Beacon Large Cap Value Adv
Price$22.93
Change+$0.21 (+0.92%)
VolumeN/A
Net Assets3.24B
American Funds American Mutual R4
Price$60.09
Change+$0.76 (+1.28%)
VolumeN/A
Net Assets107.77B
AVASX vs RMFEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AVASX vs. RMFEX commentary
Aug 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVASX is a Hold and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 108B vs. AVASX (3.24B). RMFEX (1.51) and AVASX (1.48) have matching dividends . AVASX was incepted earlier than RMFEX: AVASX (20 years) vs RMFEX (23 years). AVASX (1.12) is less costly to investors than RMFEX (0.62). RMFEX is a more actively managed with annual turnover of: 31.00 vs. AVASX (26.00). RMFEX has a lower initial minimum investment than AVASX: RMFEX (250) vs AVASX (2500). RMFEX annual gain was more profitable for investors over the last year : 9.89 vs. AVASX (-3.73). RMFEX return over 5 years is better than : 58.94 vs. AVASX (13.62).
AVASXRMFEXAVASX / RMFEX
Total Expense Ratio1.120.62181%
Annual Report Gross Expense Ratio1.120.62181%
Fund Existence20 years23 years-
Gain YTD3.74410.24337%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.24B108B3%
Annual Yield % from dividends1.481.5198%
Returns for 1 year-3.739.89-38%
Returns for 3 years2.0627.527%
Returns for 5 years13.6258.9423%
Returns for 10 years-9.5386.68-11%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGHRX32.60N/A
N/A
Hartford Healthcare R3
JDEUX45.86N/A
N/A
JPMorgan US Research Enhanced Equity R6
MWEGX38.39N/A
N/A
MFS Global Equity R1
MXMTX10.42N/A
N/A
Empower Small Cap Growth Investor
FEXRX11.40N/A
N/A
First Eagle U.S. SMID Cap Opportunity R6